MPE had higher proportions of CD45+ immune cells and CD3+ T cells (70.5% vs 50%) compared with tumor and was enriched for effector CD8+ T cells, CCR7C−D45RA− effector memory CD4+ T cells, and quiescent CD25highCD127low regulatory CD4+ T cells. The gene discussed is PTPRC; the disease is neoplasm.